Abbott MediaRoom (Innovation ) https://abbott.mediaroom.com/ New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents https://abbott.mediaroom.com/2026-06-22-New-Similac-R-survey-finds-social-media-pressure-to-be-perfect-is-fueling-a-shift-toward-authenticity-for-the-next-generation-of-parents Mon, 22 Jun 2026 12:00:00 -0400 https://abbott.mediaroom.com/2026-06-22-New-Similac-R-survey-finds-social-media-pressure-to-be-perfect-is-fueling-a-shift-toward-authenticity-for-the-next-generation-of-parents New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis https://abbott.mediaroom.com/2026-06-06-New-Abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis Sat, 06 Jun 2026 09:00:00 -0400 https://abbott.mediaroom.com/2026-06-06-New-Abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes https://abbott.mediaroom.com/2026-05-27-Abbott-secures-CE-Mark-for-worlds-first-dual-glucose-ketone-sensing-technology-for-people-with-diabetes Wed, 27 May 2026 09:00:00 -0400 https://abbott.mediaroom.com/2026-05-27-Abbott-secures-CE-Mark-for-worlds-first-dual-glucose-ketone-sensing-technology-for-people-with-diabetes Abbott to highlight expanding cancer diagnostic portfolio and clinical evidence at Digestive Disease Week (DDW) 2026 https://abbott.mediaroom.com/press-releases?item=124750 Thu, 30 Apr 2026 09:00:00 -0400 https://abbott.mediaroom.com/press-releases?item=124750 Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform https://abbott.mediaroom.com/2026-04-28-Abbott-receives-FDA-clearance-and-CE-Mark-for-next-generation-Ultreon-TM-3-0-AI-powered-coronary-imaging-platform Tue, 28 Apr 2026 09:00:00 -0400 https://abbott.mediaroom.com/2026-04-28-Abbott-receives-FDA-clearance-and-CE-Mark-for-next-generation-Ultreon-TM-3-0-AI-powered-coronary-imaging-platform